Ghana prepares to issue cannabis cultivation licenses for medicine and industry
Ghana is moving closer to allowing industrial and medicinal cannabis cultivation, following a 2020 law change. The Narcotic Control Commission has announced that cultivation licenses will be issued soon. This step could tap into a global market projected to exceed USD 18 billion by 2027.
The policy shift aims to turn cannabis into a cash crop, mirroring moves by countries like Lesotho, South Africa, and Malawi. But challenges remain before farming can begin in earnest.
In 2020, Ghana amended its Narcotic Control Commission Act to permit cannabis cultivation for industrial and medicinal use. The law allows plants with THC levels of 0.3% or lower. Despite this change, implementation has stalled due to unresolved cost and regulatory hurdles.
The country's climate offers ideal growing conditions, with potential for four harvests a year. Cannabis grows quickly, and just one acre can produce as much paper pulp as 4 to 20 acres of trees over 20 years. This could cut Ghana's reliance on imported paper.
Cannabis also has proven medicinal benefits, including reducing inflammation, protecting nerve cells, and treating chronic pain and anxiety. These uses add to its economic appeal.
Yet obstacles stand in the way. Ghana lacks research expertise, farming infrastructure, and funding. Strict regulations and fears of recreational misuse add further complications. To address these, officials suggest learning from Lesotho and Malawi by encouraging private investment, tax breaks, and low-interest loans for farmers.
The Narcotic Control Commission has now reassured the public that licenses will be issued shortly. This marks a key step toward launching the cannabis industry.
Once licenses are granted, Ghana could enter a growing global cannabis market. The crop's fast growth and multiple uses—from medicine to paper—offer clear economic benefits. But success will depend on overcoming funding gaps, building expertise, and enforcing tight controls.
